Scleroderma and Raynaud's UK
At a glance
Key takeaways
- This funder pays for scientific research into scleroderma and Raynaud's, so it suits a team that can lead or closely partner on a research project rather than a general support request.
- Its one stated award is £100,000 in an open call, and its annual report shows £159,183 awarded in total, so size any request to a single project.
- The research grant call asks multidisciplinary teams for an expression of interest first, with full applications opening in late October and closing in January, and only successful expressions are invited to apply in full.
- Its reported organisational awards have gone to university and hospital research settings, and the SRUK Grant Call excludes applicants who are not multidisciplinary teams and proposals that are not proof of concept or feasibility studies, while the SRUK-MRC Clinical Research Training Fellowship is open only to registered healthcare professionals.
- Its information does not say how competitive the calls are, but applications are peer reviewed and trustees decide on merit or the funding available.
Overview
Scleroderma and Raynaud's UK is a charity registered with the Charity Commission for England and Wales (charity number 1161828).
Scleroderma and Raynaud's UK exists to relieve people suffering from scleroderma and Raynaud's and related disorders, including through financial support for those in need, and its mission is to improve the lives of everyone affected by the conditions. It is registered with the Charity Commission for England and Wales under charity number 1161828. Its annual report shows £159,183 awarded. It runs annual grant calls for high-quality research and offers a range of other funding opportunities, including the SRUK-MRC Clinical Training Research Fellowship, which operates on a rolling basis with three opportunities to apply each year.
What they fund
Priority Areas
SRUK funds innovative, high-quality scientific research into the causes, progression and treatment of Scleroderma and Raynaud’s, to improve outcomes and ultimately find a cure. Its research strategy centres on precision-medicine approaches to treatment, early detection and diagnosis, improving quality of life, and understanding the causes of both conditions. It supports a diverse range of research projects and runs annual grant calls; applications are reviewed by peer reviewers, whose recommendations go to trustees. Its reported organisational awards have gone to university and hospital research settings, and its calls invite multidisciplinary teams. The research is intended to benefit people and families affected by the conditions and the health professionals involved in their management. Trustees approve or reject applications on merit or according to the funding available.
Themes
- Precision medicine
- Early detection & diagnosis
- Quality of life
- Causes of disease
What they don't fund
- SRUK Grant Call 2026 only:
- proposals that do not investigate stratified approaches to achieving better systemic sclerosis treatment
- applicants who are not multidisciplinary teams
- proposals that are not proof of concept or feasibility proposals
- SRUK-MRC Clinical Research Training Fellowship only: applicants who are not registered healthcare professionals
How to apply
For its research grant call, multidisciplinary teams submit an expression of interest first. Successful applicants are invited to submit a full application, pending Research Committee review.
Deadlines: The research grant call is held annually.
Application windows:
- SRUK Grant Call: Full Application: Opens in late October, closes in January
Who can apply:
- SRUK Grant Call: Multidisciplinary teams
- SRUK-MRC Clinical Research Training Fellowship: Registered healthcare professionals
Application success factors
What the charity says:
- The research should be innovative and high quality.
- Projects should align with SRUK’s mission and its four research strategy themes.
- Peer reviewers assess applications and report recommendations to trustees, who decide on merit or the funding available.
Where they fund
Registered area of operation (Charity Commission)
Similar funders
Funders supporting work similar to Scleroderma and Raynaud's UK.
Five years of accounts
| Financial year | Income | Expenditure | Grants paid | Accounts document |
|---|---|---|---|---|
| year to 31 March 2021 | £2,305,635 | £1,216,971 | £487,327 | Accounts for year to 31 March 2021 |
| year to 31 March 2022 | £2,013,104 | £1,120,106 | £280,688 | Accounts for year to 31 March 2022 |
| year to 31 March 2023 | £822,185 | £1,128,071 | £67,479 | Accounts for year to 31 March 2023 |
| year to 31 March 2024 | £997,920 | £1,386,407 | £149,952 | Accounts for year to 31 March 2024 |
| year to 31 March 2025 | £432,503 | £1,520,269 | £159,183 | Accounts for year to 31 March 2025 |
Income vs grants paid
IncomeGrants paid
Total value each financial year
Grants paid stayed within income across the 5 years shown.
- Grants paid, year to 31 March 2021; year to 31 March 2022; year to 31 March 2023; year to 31 March 2024: grants to institutions, as reported on the charity register (Part B).
- Grants paid, year to 31 March 2025: grants awarded in the year, as reported in the accounts.
Figures from the charity’s filed accounts and its register entry. The document icon links to the charity’s entry on the Charity Commission register, where its filed accounts can be found.
Sources
Registers and filings
Other sources
- sruk.co.uk
- sruk.co.uk/research · read on 30 October 2026
- sruk.co.uk/sruk-grant-call-2026 · read on 30 October 2026
- sruk.co.uk/research/for-researchers/funding-opportunities · read on 30 October 2026
- Annual report (year to 31 March 2025)
This profile draws on the funder’s own website as well as its filed accounts.
Sources last checked on 30 October 2026.
🎯 You've done the research. Now write an application they can't refuse.
Hinchilla combines funder's specific priorities with your organisation's past successful grants and AI analysis of what reviewers want to see.
Data privacy and security by default
Your organisation's past successful grants and experience
AI analysis of what reviewers want to see
A compelling draft application in 10 minutes instead of 10 hours
Spotted something that needs correcting? Let us know
At a glance
Applying to Scleroderma and Raynaud's UK?
Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.
No credit card required
Applying to Scleroderma and Raynaud's UK?
Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.
No credit card required